PMN to the moon, let's ride!https://www.ihealthcareanalyst.com/global-alzheimers-disease-market/
The global market for Alzheimer’s disease estimated to reach $15.5 billion by 2031, growing at a staggering double-digit CAGR of 32.9% over the forecast period, driven by rapidly ageing population, increasing prevalence of AD, coupled with approval of anti-amyloid mAbs and technological advancements in diagnostics and biomarkers.